Trebananib Completed Phase 2 Trials for Inoperable Hepatocellular Carcinoma / Advanced Hepatocellular Carcinoma Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00872014A Study of the Effectiveness and Safety of AMG 386 and Sorafenib to Treat Advanced or Inoperable Hepatocellular Cancer